Is JHX Stock a Buy Sell or Hold?
James Hardie Industries (NYSE:JHX) is a manufacturer of outside building…
Sell
39
CNVVY Quote, Financials, Valuation and Earnings
Last price:
$13.42
Seasonality move
:
7.4%
Day range:
$13.38 - $13.50
52-week range:
$10.77 - $15.40
Dividend yield:
1.89%
P/E ratio:
36.08x
P/S ratio:
3.01x
P/B ratio:
4.06x
Volume:
10.5K
Avg. volume:
40.8K
1-year change:
-8.83%
Market cap:
$6.9B
Revenue:
$2.3B
EPS (TTM):
$0.37
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, ConvaTec Group PLC has -- downside to fair value with a price target of -- per share.
CNVVY vs. S&P 500
-
Over the past 5 trading days, ConvaTec Group PLC has overperformed the S&P 500 by 1.51% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
ConvaTec Group PLC does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
ConvaTec Group PLC has grown year-over-year revenues for 0 quarters straight. In the most recent quarter ConvaTec Group PLC reported revenues of --.
Earnings Growth
-
ConvaTec Group PLC has grown year-over-year earnings for 0 quarters straight. In the most recent quarter ConvaTec Group PLC reported earnings per share of --.
Enterprise value:
7.9B
EV / Invested capital:
--
Price / LTM sales:
3.01x
EV / EBIT:
24.79x
EV / Revenue:
3.46x
PEG ratio (5yr expected):
0.18x
EV / Free cash flow:
28.88x
Price / Operating cash flow:
25.18x
Enterprise value / EBITDA:
14.66x
Gross Profit (TTM):
$1.3B
Return On Assets:
5.27%
Net Income Margin (TTM):
8.32%
Return On Equity:
11.35%
Return On Invested Capital:
6.56%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2017-06-30 | 2018-06-30 | 2019-06-30 | 2018-06-30 | 2019-06-30 | |
| Income Statement | ||||||
| Revenue | $1.7B | $1.9B | $1.8B | -- | -- | |
| Gross Profit | $897.9M | $977.7M | $952.6M | -- | -- | |
| Operating Income | $188.1M | $277M | $239.3M | -- | -- | |
| EBITDA | $280.1M | $454.7M | $438.1M | -- | -- | |
| Diluted EPS | -$0.23 | $0.48 | $0.32 | -- | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $1.2B | $1.1B | $889.3M | $870M | $793.3M | |
| Total Assets | $3.8B | $3.7B | $3.6B | $3.7B | $3.5B | |
| Current Liabilities | $513.2M | $569.2M | $533.1M | $536.4M | $512.3M | |
| Total Liabilities | $2.1B | $2B | $2B | $2B | $1.8B | |
| Total Equity | $1.7B | $1.7B | $1.6B | $1.7B | $1.7B | |
| Total Debt | $1.5B | $1.3B | $1.2B | $1.2B | $1.1B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2013-03-31 | 2014-03-31 | 2015-03-31 | 2014-03-31 | 2015-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | $10B | $10.9B | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | $11.6B | $13.7B | |
| Free Cash Flow | -- | -- | -- | -- | -- | |
CNVVY
Sector
Market Cap
$6.9B
$36.5M
Price % of 52-Week High
87.14%
44.66%
Dividend Yield
1.89%
0%
Shareholder Yield
--
-0.9%
1-Year Price Total Return
-8.83%
-39.9%
Beta (5-Year)
0.984
0.774
Dividend yield:
1.89%
Annualized payout:
$0.25
Payout ratio:
68.35%
Growth streak:
2 years
Technicals
8-day SMA
Sell
Level
$13.49
200-day SMA
Buy
Level
$12.24
Bollinger Bands (100)
Buy
Level
11.3 - 13.16
Chaikin Money Flow
Buy
Level
1.4K
20-day SMA
Sell
Level
$13.69
Relative Strength Index (RSI14)
Buy
Level
50.93
ADX Line
Sell
Level
11.64
Williams %R
Neutral
Level
-59.6491
50-day SMA
Buy
Level
$12.83
MACD (12, 26)
Buy
Level
3.68
25-day Aroon Oscillator
Buy
Level
36
On Balance Volume
Sell
Level
-29.6K
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.6382)
Buy
CA Score
(Annual)
Level (0.0339)
Buy
Beneish M-Score
(Annual)
Level (-2.7499)
Buy
Momentum Score
Level (6)
Buy
Ohlson Score
Level (-0.551)
Buy
Piotroski F Score
(Annual)
Level (8)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Originally spun out of Bristol-Myers Squibb, ConvaTec designs, manufactures, and markets advanced wound care, ostomy, continence care, and infusion sets for the acute-care hospital and chronic-care home settings. Advanced wound care and ostomy supplies are the largest divisions, accounting for 33% and 28% of total revenue, respectively. Continence care has become a slightly smaller business (21% of revenue) following the decision to exit the acute care market, and infusion sets contribute 18% of consolidated revenue.
Stock Forecast FAQ
In the current month, CNVVY has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The CNVVY average analyst price target in the past 3 months is --.
-
Where Will ConvaTec Group PLC Stock Be In 1 Year?
According to analysts, the consensus estimate is that ConvaTec Group PLC share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About ConvaTec Group PLC?
Analysts are divided on their view about ConvaTec Group PLC share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that ConvaTec Group PLC is a Sell and believe this share price will rise from its current level to --.
-
What Is ConvaTec Group PLC's Price Target?
The price target for ConvaTec Group PLC over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is CNVVY A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for ConvaTec Group PLC is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of CNVVY?
You can purchase shares of ConvaTec Group PLC via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase ConvaTec Group PLC shares.
-
What Is The ConvaTec Group PLC Share Price Today?
ConvaTec Group PLC was last trading at $13.42 per share. This represents the most recent stock quote for ConvaTec Group PLC. Yesterday, ConvaTec Group PLC closed at $13.42 per share.
-
How To Buy ConvaTec Group PLC Stock Online?
In order to purchase ConvaTec Group PLC stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Did Buffett Sell the S&P 500?
Warren Buffett has always been an advocate of investing in…
Will SoundHound AI Stock Recover?
SoundHound AI (NASDAQ:SOUN) is a leading maker of artificial intelligence…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 36x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 32x
Sell
41
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 37x
Alerts
Buy
78
AJINY alert for Mar 29
Ajinomoto [AJINY] is up 99.61% over the past day.
Buy
69
AGX alert for Mar 29
Argan [AGX] is up 19.83% over the past day.
Sell
24
AIR alert for Mar 29
AAR [AIR] is down 16.36% over the past day.
